-
admin
Posts
Vantage Joins as Titanium Sponsor at Money Expo Mexico 2025
PORT VILA, Vanuatu, Feb. 10, 2025 /PRNewswire/ — Vantage Markets is excited to announce its participation as a Titanium Sponsor at the highly anticipated Money...
JinkoSolar Tops Wood Mackenzie’s Global Solar Module Manufacturers Ranking 2025
SHANGRAO, China, Feb. 10, 2025 /PRNewswire/ — JinkoSolar Holding Co., Ltd. (“JinkoSolar” or the “Company”) (NYSE: JKS), one of the largest and most innovative solar module...
Ricoh recognised by Gartner® in its first 2024 Magic Quadrant™ for Document Management
TOKYO, Feb. 10, 2025 /PRNewswire/ — Ricoh has been positioned by Gartner, Inc. in its 2024 Magic Quadrant™ for Document Management, report. This is the...
Axcelis Announces Participation in SEMICON Korea 2025
Learn About the Latest Products and Upgrades that Accelerate Intelligent Solutions in Ion Implant BEVERLY, Mass., Feb. 10, 2025 /PRNewswire/ — Axcelis Technologies, Inc. (Nasdaq: ACLS),...
SANS PRĖCĖDENT – TWO LEGENDS EXPLORE ONE OF THE WORLD’S MOST RESPECTED VARIETALS
ADELAIDE, Australia, Feb. 10, 2025 /PRNewswire/ — Introducing Grange La Chapelle 2021, the result of curiosity and exploration that united cultures across two hemispheres. A...
Billion Electric Group Delivers 100% Green Energy to Pacific Islands with Smart Solar-Storage Microgrids
KOROR, Palau, Feb. 9, 2025 /PRNewswire/ — Billion Electric Group (TWSE: 3027), in collaboration with Taiwanese partners, has successfully deployed 495 kWp of solar PV...
Billion Electric Group Delivers 100% Green Energy to Pacific Islands with Smart Solar-Storage Microgrids
KOROR, Palau, Feb. 9, 2025 /PRNewswire/ — Billion Electric Group (TWSE: 3027), in collaboration with Taiwanese partners, has successfully deployed 495 kWp of solar PV and...
Saudi Arabia’s KFSHRC Continues to Rise as a Globally Renowned Medical Centre
RIYADH, Saudi Arabia, Feb. 09, 2025 (GLOBE NEWSWIRE) — Saudi Arabia’s King Faisal Specialist Hospital & Research Centre (KFSHRC) – the region’s top-ranked hospital – has...
EYLEA HD® (aflibercept) Injection 8 mg Positive Phase 3 Results in Patients with Macular Edema following Retinal Vein Occlusion Presented at Angiogenesis Meeting
EYLEA HD led to improved vision with extended dosing intervals, achieving non-inferior vision gains with an every 8-week dosing regimen compared to EYLEA® (aflibercept) Injection...
Three-Year Results for EYLEA HD® (aflibercept) Injection 8 mg in Patients with Wet Age-related Macular Degeneration Demonstrate Continued Durable Vision Gains and Anatomic Improvements with Extended Dosing Intervals
At three years of EYLEA HD treatment, the vast majority of patients maintained visual and anatomic improvements while achieving extended dosing regimens, including those of...
